Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment-free Remission Accomplished With Dasatinib in Patients With CML

NCT02268370 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02268370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02268370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2014
Completion date
October 31, 2021
Enrollment
131 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia